UB Paderborn / Katalog / Suche / in CDI

1 – 10 von 10

Sortiert nach

Discovery of a nanomolar inhibitor of lung adenocarcinoma in vitro

Bioorganic & medicinal chemistry letters, 2014-11, Vol.24 (21), p.5107-5110

2014

Volltextzugriff (PDF)

Chutes and ladders in hepatitis C nucleoside drug development

Antiviral research, 2014-02, Vol.102, p.119-147

2014

Volltextzugriff (PDF)

Nucleotide Substrate Specificity of Anti-Hepatitis C Virus Nucleoside Analogs for Human Mitochondrial RNA Polymerase

Antimicrobial agents and chemotherapy, 2017-08, Vol.61 (8)

2017

Volltextzugriff (PDF)

Efficient synthesis of 5′-O(N)-carbamyl and -polycarbamyl nucleosides

Tetrahedron letters, 2013-12, Vol.54 (50), p.6882-6885

2013

Volltextzugriff (PDF)

Biochemical Characterization of the Active Anti-Hepatitis C Virus Metabolites of 2,6-Diaminopurine Ribonucleoside Prodrug Compared to Sofosbuvir and BMS-986094

Antimicrobial agents and chemotherapy, 2016-08, Vol.60 (8), p.4659-4669

2016

Volltextzugriff (PDF)

A broad spectrum anticancer nucleoside with selective toxicity against human colon cells in vitro

Bioorganic & medicinal chemistry letters, 2011-03, Vol.21 (5), p.1484-1487

2011

Volltextzugriff (PDF)

Synthesis and SAR of 2′,3′-bis-O-substituted N6, 5′-bis-ureidoadenosine derivatives: Implications for prodrug delivery and mechanism of action

Bioorganic & medicinal chemistry letters, 2012-10, Vol.22 (19), p.6067-6071

2012

Volltextzugriff (PDF)

Synthesis and SAR of 2',3'-bis-O-substituted N(6), 5'-bis-ureidoadenosine derivatives: implications for prodrug delivery and mechanism of action

Bioorganic & medicinal chemistry letters, 2012-10, Vol.22 (19), p.6067-6071

2012

Volltextzugriff (PDF)

Synthesis, SAR, and preliminary mechanistic evaluation of novel antiproliferative N6,5′-bis-ureido- and 5′-carbamoyl-N6-ureidoadenosine derivatives

Bioorganic & medicinal chemistry, 2012-01, Vol.20 (2), p.1008-1019

2012

Volltextzugriff (PDF)

Synthesis, SAR, and preliminary mechanistic evaluation of novel antiproliferative N6,5'-bis-ureido- and 5'-carbamoyl-N6-ureidoadenosine derivatives: Symposium-in-Print: Chemical Proteomics

Bioorganic & medicinal chemistry, 2012, Vol.20 (2), p.1008-1019

2012

Volltextzugriff (PDF)

1 – 10 von 10

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(10)
Mit Volltextzugriff
(10)

Publikationsform

Artikel
(10)

Sprache

Englisch
(10)

Erscheinungsjahr

n.n

Kollektion

2 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

Menü

Weitere Dienste

Einstellungen

Discovery of a nanomolar inhibitor of lung adenocarcinoma in vitro

Chutes and ladders in hepatitis C nucleoside drug development

Nucleotide Substrate Specificity of Anti-Hepatitis C Virus Nucleoside Analogs for Human Mitochondrial RNA Polymerase

Efficient synthesis of 5′-O(N)-carbamyl and -polycarbamyl nucleosides

Biochemical Characterization of the Active Anti-Hepatitis C Virus Metabolites of 2,6-Diaminopurine Ribonucleoside Prodrug Compared to Sofosbuvir and BMS-986094

A broad spectrum anticancer nucleoside with selective toxicity against human colon cells in vitro

Synthesis and SAR of 2′,3′-bis-O-substituted N6, 5′-bis-ureidoadenosine derivatives: Implications for prodrug delivery and mechanism of action

Synthesis and SAR of 2',3'-bis-O-substituted N(6), 5'-bis-ureidoadenosine derivatives: implications for prodrug delivery and mechanism of action

Synthesis, SAR, and preliminary mechanistic evaluation of novel antiproliferative N6,5′-bis-ureido- and 5′-carbamoyl-N6-ureidoadenosine derivatives

Synthesis, SAR, and preliminary mechanistic evaluation of novel antiproliferative N6,5'-bis-ureido- and 5'-carbamoyl-N6-ureidoadenosine derivatives: Symposium-in-Print: Chemical Proteomics

Suchergebnisse filtern